Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers

Eur Respir J. 2020 Feb 27;55(2):2000048. doi: 10.1183/13993003.00048-2020. Print 2020 Feb.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Inhalation
  • Bronchodilator Agents
  • Carbon*
  • Environment
  • Humans
  • Metered Dose Inhalers
  • Nebulizers and Vaporizers*
  • Policy

Substances

  • Bronchodilator Agents
  • Carbon